COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 32 filers reported holding COCRYSTAL PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $467,000 | -33.1% | 1,604,425 | -5.7% | 0.00% | 0.0% |
| Q2 2022 | $698,000 | -25.5% | 1,702,238 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $937,000 | -24.3% | 1,704,328 | -10.4% | 0.00% | -50.0% |
| Q4 2021 | $1,237,000 | -41.9% | 1,902,925 | -6.1% | 0.00% | -33.3% |
| Q3 2021 | $2,128,000 | -34.4% | 2,026,766 | -21.9% | 0.00% | -25.0% |
| Q2 2021 | $3,242,000 | -45.2% | 2,593,933 | -39.0% | 0.00% | -42.9% |
| Q1 2021 | $5,914,000 | +10.1% | 4,254,880 | +7.7% | 0.01% | +16.7% |
| Q4 2020 | $5,372,000 | +51.1% | 3,949,980 | +3.3% | 0.01% | +50.0% |
| Q3 2020 | $3,555,000 | -23.8% | 3,824,380 | +24.5% | 0.00% | 0.0% |
| Q2 2020 | $4,668,000 | +331.4% | 3,071,323 | +101.6% | 0.00% | +300.0% |
| Q1 2020 | $1,082,000 | +1590.6% | 1,523,423 | +1078.4% | 0.00% | – |
| Q4 2019 | $64,000 | +190.9% | 129,274 | +1128.8% | 0.00% | – |
| Q3 2019 | $22,000 | – | 10,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 6,110,657 | $7,638,000 | 1.08% |
| Altium Capital Management LP | 776,000 | $970,000 | 0.22% |
| Alyeska Investment Group, L.P. | 2,750,100 | $3,438,000 | 0.04% |
| Virtu Financial LLC | 116,625 | $146,000 | 0.01% |
| Parallel Advisors, LLC | 184,708 | $231,000 | 0.01% |
| Renaissance Technologies | 2,593,933 | $3,242,000 | 0.00% |
| CIM, LLC | 11,000 | $12,000 | 0.00% |
| Western Wealth Management, LLC | 19,115 | $24,000 | 0.00% |
| Mariner, LLC | 200,055 | $250,000 | 0.00% |
| BRIGHTON JONES LLC | 36,000 | $45,000 | 0.00% |